Violette Shelia M.
SEC CIK 2016144 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QTTB | Q32 Bio Inc. | CSO | 127.8K | — | $64.4K | 8 | 2024-10-08 | 2026-08-25 |
Most active insiders at QTTB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Xu Diyong | Dir, 10% | $15.00M | — |
| 2 | ORBIMED ADVISORS LLC | Dir, 10% | $15.00M | — |
| 3 | Morrison Jodie Pope | CEO, Dir | — | $285.5K |
| 4 | Kalowski Lee | CFO, Pres | — | $115.2K |
| 5 | Violette Shelia M. | CSO | — | $59.0K |
| 6 | Manke Isaac | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-27 16:10 | 2026-08-25 | QTTB | Q32 Bio Inc. | Violette Shelia M. | CSO | S - Sale | $16.56 | -2,798 | 127.8K | -2% | -$46.3K | |
| 2026-07-20 21:31 | 2026-07-16 | QTTB | Q32 Bio Inc. | Violette Shelia M. | CSO | A - Grant | $0.00 | +37.5K | 130.6K | +40% | $0 | |
| 2026-03-20 | 2026-02-24 | QTTB | Q32 Bio Inc. | Violette Shelia M. | CSO | A - Grant | $0.00 | +37.5K | 93.1K | +67% | $0 | |
| 2026-02-27 | 2026-02-25 | QTTB | Q32 Bio Inc. | Violette Shelia M. | CSO | S - Sale | $4.51 | -2,815 | 55.6K | -5% | -$12.7K | |
| 2025-08-28 | 2025-08-26 | QTTB | Q32 Bio Inc. | Violette Shelia M. | CSO | S - Sale | $1.80 | -2,990 | 58.4K | -5% | -$5,382 | |
| D | 2025-02-26 | 2025-02-24 | QTTB | Q32 Bio Inc. | Violette Shelia M. | CSO | A - Grant | $0.00 | +37.5K | 61.4K | +157% | $0 |
| DM | 2024-10-16 | 2024-10-11+ | QTTB | Q32 Bio Inc. | Violette Shelia M. | CSO | M - OptEx | $5.49 | +10.6K | 23.9K | +80% | +$58.0K |
| D | 2024-10-10 | 2024-10-08 | QTTB | Q32 Bio Inc. | Violette Shelia M. | CSO | M - OptEx | $3.12 | +13.3K | 13.3K | New | +$41.5K |
Purchase Sale Sale after option exercise All abbreviations